Benjamin Luby, PhD

Senior Analyst

Dr. Luby began work for the inThought team in 2022. Prior to inThought, he worked for a medical diagnostics start-up working in business development and product strategy for their nanoparticle-based diagnostic device. Dr. Luby received his Ph.D. from the University of Toronto in Biomedical Engineering, where he developed a novel mechanism of action for a fluorescence-based microRNA sensor. He received his B.Sc. in Biochemistry from McGill University in Montréal, focusing specifically on organic chemistry, pharmacology, and oncology.

Contact us

Learn how inThought Labs can simplify your life and empower your team with expert consultants and our cloud-based system, inVision.

Chris Martin

President

As the president of inThought Labs, Chris is focused on constantly improving inVision, the leading competitive and market intelligence platform for the biopharmaceutical industry, to better meet the changing needs of clients.

 

With 20 years of experience in roles being a consumer of market and competitive information, Chris understands the needs and priorities of clients. Chris was a senior principal and co-founder of inThought, a life science consulting, market research, and analytics firm. Collaborating with Ben Weintraub, Chris also co-founded BiotechTracker, an online tool for investors and precursor to inVision. Previous to inThought, he was a healthcare analyst and co-portfolio manager at two investment firms. Chris served in health care policy roles at the White House Office of Management and Budget. These roles included Medicare Desk Officer at the Office of Information and Regulatory Affairs, where he was responsible for providing recommendations to senior White House policy officials on healthcare policies and regulations.

 

Chris has a Master in Business Administration from Harvard Business School, a Master in Engineering from Villanova University, and a Bachelor of Science in Engineering from Cornell University. Prior to attending Harvard Business School, Chris served on two U.S. Navy nuclear submarines and at the Pentagon.